A carregar...

Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model

The endothelin-1 antagonist, Atrasentan (ABT-627) was used to modify perfusion in the human tumor xenograft model, HT29, growing in nude mice. Atrasentan produced a significant increase in perfusion, as measured in vivo by Gd-DTPA DCE-MRI. Changes in tumor hypoxia were assessed by comparing the bind...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yang, Kwang Mo, Russell, James, Lupu, Mihaela E., Cho, HyungJoon, Li, Xiao-Feng, Koutcher, Jason A., Ling, C. Clifton
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2892788/
https://ncbi.nlm.nih.gov/pubmed/19717985
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!